These compounds may interact with:
cAMP-specific 3',5'-cyclic phosphodiesterase 4B
Potentially involved in: lymphoid leukemia; heart disease; carcinoma; type 2 diabetes mellitus; schizophrenia; bipolar disorder; acrodysostosis; chronic obstructive pulmonary disease; asthma; alcoholic intoxication, chronic; autistic disorder; mental depression; depressive disorder; leukemia, myelocytic, acute; dermatologic disorders; myocardial ischemia; amphetamine-related disorders; arsenic poisoning; active crohn's disease; acute quadriplegic myopathy
Disease data sourced from Pharos.